When a company decides to innovate, the most common reaction is to structure everything internally: hire researchers, build laboratories, acquire equipment, and create an in-house R&D department.
The logic seems intuitive. If innovation is strategic, then technological development should happen inside the company.
In practice, however, this path is not always the most efficient.
Building internal research capacity requires significant investment, time to mature, and a constant flow of projects to justify the structure. Forming scientific teams, developing deep technical capabilities, and assembling laboratory infrastructure can take years… sometimes decades.
For many companies, the challenge is not only financial. It is also about time.
While the internal structure is being built, the market continues to move forward.
Technological development does not need to happen inside the company
An alternative increasingly adopted by innovative companies is accessing external technological capabilities, especially through partnerships with Research and Technology Organizations (RTOs).
Universities and research centers accumulate decades of knowledge in critical areas such as artificial intelligence, advanced materials, biotechnology, embedded systems, energy, healthcare, and advanced manufacturing.
Beyond scientific knowledge, these institutions concentrate something even harder to build internally: critical mass of researchers and specialized technological infrastructure.
Advanced laboratories, sophisticated equipment, and teams with years of experience in applied research are already available in these environments.
By connecting to these capabilities, companies can significantly accelerate their technological development.
The global logic of innovation
In the world’s leading innovation ecosystems, technological development rarely happens in isolation within companies.
Universities and research centers deepen scientific and technological knowledge. Companies transform that knowledge into scalable products, services, and business models.
This complementarity allows each actor to focus on what they do best.
While research pushes technological frontiers forward, the market focuses on transforming those technologies into economic value.
More speed, less risk
When a company decides to develop technology in partnership with RTOs, three strategic advantages emerge.
Speed.
The company gains access to capabilities and infrastructure that would take years to build internally.
Reduction of technological risk.
Projects are conducted by highly specialized teams accustomed to dealing with scientific and technological uncertainty.
Investment efficiency.
Instead of maintaining a permanent R&D structure, the company invests directly in developing solutions for its specific technological challenges.
This model allows companies to explore more advanced technologies without compromising organizational agility.
The role of funding instruments
In Brazil, this type of collaboration between companies and research institutions is also supported by instruments designed to enable technological development projects.
One example is the model created by EMBRAPII, which accredits research centers in universities and technological institutes to work directly with companies.
The distinctive feature of this model is that part of the investment in a project can be shared with public funds previously allocated to the research units.
In practice, this reduces the cost of technological development for companies and accelerates the start of projects, since the resources are already decentralized within accredited institutions.
More than a funding program, it is a mechanism designed to connect companies with the scientific and technological capabilities that already exist in the country.
Innovation does not mean doing everything alone
There is a persistent myth that innovation is only strategic when it happens inside the company.
Reality shows something different.
Companies that innovate faster usually operate in networks. They connect with universities, research centers, and technological ecosystems to access knowledge, reduce risk, and accelerate the development of new solutions.
In this context, the strategic question is no longer:
“Should we develop technology inside or outside the company?”
Instead, the better question becomes:
“What is the smartest way to access the technology we need to develop?”
In many cases, the answer begins outside the company’s laboratory… and within a strategic partnership with those who have already been building that technology for years.